This Article Full Text Full Text (PDF) All Versions of this Article: 51/6/1426    most recent HYPERTENSIONAHA.106.085944v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mark, A. L. Search for Related Content PubMed PubMed Citation Articles by Mark, A. L. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Obesity Related Collections Other hypertension

(Hypertension. 2008;51:1426.)
© 2008 American Heart Association, Inc.

Controversies in Hypertension

Dietary Therapy for Obesity: An Emperor With No Clothes

From the Carver College of Medicine, Center on Functional Genomics of Hypertension, and Department of Internal Medicine, University of Iowa, Iowa City.

Correspondence to Allyn L. Mark, Carver Professor of Medicine, Carver College of Medicine, Center on Functional Genomics of Hypertension, 3111F MERF, University of Iowa, Iowa City, IA 52242-1101. E-mail Allyn-Mark@uiowa.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The prevalence of obesity has increased substantially in the past 3 decades and is projected to increase further in the years ahead. It increases the risk of diabetes mellitus, dyslipidemia, hypertension, cardiovascular disease, sleep apnea, nonalcoholic hepatic steatosis, gallbladder disease, osteoarthritis, and cancer. The prevention and treatment of obesity is, therefore, a leading challenge facing public health and medicine in the 21st century.

Two stereotypes have dominated thinking in public health, medicine, and the media about obesity. The first stereotype is that the recent surge in prevalence of obesity reflects almost entirely environmental and psychological factors and excludes an important contribution of genetic biological factors. The second stereotype is that obesity should and can be treated primarily by diet and behavioral modification. In this review, I challenge these tenets.

I summarize evidence for a strong genetic neurobiological contribution to adiposity and body weight and assert that common human obesity is, like essential hypertension, a complex multifactorial disease where genetic factors promote sensitivity or resistance to obesity in a toxic environment. This concept of a genetic resistance versus sensitivity to obesity helps explain why many people remain thin in a toxic environment whereas others develop profound obesity.

I then discuss evidence that dietary therapy for obesity generally fails to achieve weight loss maintenance. There is mounting indication that the high rate of relapse from weight loss during dietary therapy occurs because of compensatory biological adaptations that promote lack of compliance and effectiveness. Relapse from weight loss during dietary therapy is not . . . [Full Text of this Article]

This article has been cited by other articles:

				D. R. Leff and D. Heath Surgery for obesity in adulthood BMJ, September 22, 2009; 339(sep22_1): b3402 - b3402. [Full Text]

				J. F. E. Mann What's new in hypertension 2008? Nephrol. Dial. Transplant., January 1, 2009; 24(1): 38 - 42. [Full Text] [PDF]

				M. E Miller and J. G Kral Surgery for obesity in older women Menopause Int, December 1, 2008; 14(4): 155 - 162. [Abstract] [Full Text] [PDF]

				T. A. Kotchen Obesity-Related Hypertension?: Weighing the Evidence Hypertension, November 1, 2008; 52(5): 801 - 802. [Full Text] [PDF]

				J. E. Hall Hypertension: Update 2008 Hypertension, September 1, 2008; 52(3): 425 - 428. [Full Text] [PDF]